Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage Hodgkin's lymphoma: Final analysis of the HD12 trial of the German Hodgkin Study Group - Borchmann, Peter; Haverkamp, Heinz; Diehl, Volker; Cerny, Thomas; Markova, Jana; Ho, Anthony Dick; Eich, Hans-Theodor; Mueller-Hermelink, Hans Konrad; Kanz, Lothar; Greil, Richard; Rank, Andreas; Paulus, Ursula; et al. (Journal of clinical oncology, 2011)
Gesehen am 02.06.2022